Exact Mass: 510.0512

Exact Mass Matches: 510.0512

Found 51 metabolites which its exact mass value is equals to given mass value 510.0512, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Leinamycin

C22H26N2O6S3 (510.0953)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

2-O-[2-O-(alpha-D-Mannopyranosyl)-alpha-D-glucopyranosyl]-3-phospho-D-glycerate

2-O-[alpha-D-mannopyranosyl-(1->2)-alpha-D-glucopyranosyl]-3-O-phospho-D-glyceric acid

C15H27O17P (510.0986)

Daidzein 4'-glucuronide-7-sulfate

(2R,4R,6R)-3,4,5-Trihydroxy-6-{4-[4-oxo-7-(sulphooxy)-4H-chromen-3-yl]phenoxy}oxane-2-carboxylic acid

C21H18O13S (510.0468)

Daidzein 7-glucuronide-4'-sulfate

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({4-oxo-3-[4-(sulfooxy)phenyl]-4H-chromen-7-yl}oxy)oxane-2-carboxylic acid

C21H18O13S (510.0468)

IB-Meca

3,4-Dihydroxy-5-(6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-N-methyloxolane-2-carboximidate

C18H19IN6O4 (510.0512)

Lormetazepam glucuronide

6-{[7-chloro-5-(2-chlorophenyl)-1-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20Cl2N2O8 (510.0597)

MCULE-7666826853

C24H16Cl2N4O5 (510.0498)

10-Deoxy-4,4-binecatorone

C30H14N4O5 (510.0964)

3,3,4,5,5,7,8-heptahydroxyl flavone-8-O-beta-D-glucuronopyranoside|floramanoside C

C21H18O15 (510.0646)

4,4-Pyranose-1,3-Hexahydroxydiphenoylglucose

C22H22O14 (510.101)

NSC289645

C25H18O12 (510.0798)

Citicoline

2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethan-1-aminium, sodium salt(1:1)

C14H25N4NaO11P2 (510.0893)

Donor of choline in biosynthesis of choline-containing phosphoglycerides.

sodium,formaldehyde,4-(4-hydroxyphenyl)sulfonylphenol,naphthalene-1-sulfonate

C23H19NaO8S2 (510.0419)

sodium 2,5-dichloro-4-[[5-cyano-2,6-bis[(2-hydroxyethyl)amino]-4-methyl-3-pyridyl]azo]benzenesulphonate

C17H17Cl2N6NaO5S (510.0256)

1H,1H,2H,2H-PERFLUOROOCTYLTRIETHOXYSILANE

C14H19F13O3Si (510.0896)

3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine-p,p′-disulfonic acid monosodium salt hydrate

C20H15N4NaO7S2 (510.028)

IB-MECA

C18H19IN6O4 (510.0512)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Piclidenoson (IB-MECA) is a first-in-class, orally active and selective A3 adenosine receptor (A3AR) agonist. Piclidenoson exhibits antiproliferative effect and induces apoptosis in different cancer cell types like melanoma, leukemia. Piclidenoson can be used for the research of autoimmune inflammatory diseases and COVID-19[1][2][3][4].

Vat Blue 6

C28H12Cl2N2O4 (510.0174)

sodium,formaldehyde,4-(4-hydroxyphenyl)sulfonylphenolate,naphthalene-1-sulfonic acid

C23H19NaO8S2 (510.0419)

450191S

C21H21Cl3N6O3 (510.0741)

Rilmazafone hydrochloride (450191S) is a benzodiazepine (omega) ligand[1].

bis(4-propan-2-ylphenyl)iodanium,hexafluorophosphate

C18H22F6IP (510.0408)

Triphenylbismuth dichloride

Dichloro(triphenyl)-λ5-bismuthane

C18H15BiCl2 (510.0355)

N-(TRIMETHOXYSILYLPROPYL)ETHYLENEDIAMINETRIACETATE, TRIPOTASSIUM SALT, 30 in water

C14H25K3N2O9Si (510.024)

2-[2-(2,4-dichloro-5-propan-2-yloxyanilino)-2-oxoethyl]sulfinyl-N-[3-(trifluoromethyl)phenyl]acetamide

C20H19Cl2F3N2O4S (510.0395)

Citicoline sodium

C14H25N4NaO11P2 (510.0893)

N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents

Lormetazepam glucuronide

6-{[7-chloro-5-(2-chlorophenyl)-1-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H20Cl2N2O8 (510.0597)

(2S,3R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-N-methyl-2-oxolanecarboxamide

C18H19IN6O4 (510.0512)

bis[2-(3-chloro-4-methoxyanilino)-2-oxoethyl] (E)-but-2-enedioate

C22H20Cl2N2O8 (510.0597)

1-(4-Chloro-3-fluorophenyl)-3-[[4-[[(4-chloro-3-fluorophenyl)carbamothioylamino]methyl]phenyl]methyl]thiourea

C22H18Cl2F2N4S2 (510.0318)

Ethyl thymidine triphosphate

C12H21N2O14P3 (510.0206)

7-Hydroxy-8-{[4-(phenyldiazenyl)phenyl]diazenyl}naphthalene-1,3-disulfonate

C22H14N4O7S2-2 (510.0304)

2-[(2-Hydroxynaphthalen-1-yl)diazenyl]-5-[(4-sulfonatophenyl)diazenyl]benzene-1-sulfonate

C22H14N4O7S2-2 (510.0304)

3,4,5-Trihydroxy-6-[[3,6,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-2,3-dihydrochromen-5-yl]oxy]oxane-2-carboxylic acid

C22H22O14 (510.101)

Cefmenoxime(1-)

C16H16N9O5S3- (510.0437)

The anion of cefmenoxime.

3,4,5-Trihydroxy-6-[2-hydroxy-4-(3,5,7-trihydroxy-6-methoxy-4-oxo-2,3-dihydrochromen-2-yl)phenoxy]oxane-2-carboxylic acid

C22H22O14 (510.101)

2-O-[alpha-D-mannopyranosyl-(1->2)-alpha-D-glucopyranosyl]-3-O-phospho-D-glyceric acid

C15H27O17P (510.0986)

3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-N-methyl-2-oxolanecarboxamide

C18H19IN6O4 (510.0512)

Daidzein 7-glucuronide-4-sulfate

C21H18O13S (510.0468)

Citicoline (sodium)

C14H25N4NaO11P2 (510.0893)

Citicoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects. Citicoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects.

(9z,13z,15z)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate

C22H26N2O6S3 (510.0953)

4,11-dihydroxy-12-{11-hydroxy-10-oxo-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-12-yl}-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-10-one

4,11-dihydroxy-12-{11-hydroxy-10-oxo-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-12-yl}-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-10-one

C30H14N4O5 (510.0964)

6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione

C21H22N2O9S2 (510.0767)

(1r,5s,6r,9r,10s,12r,15r)-6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione

(1r,5s,6r,9r,10s,12r,15r)-6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione

C21H22N2O9S2 (510.0767)

(1'r,2r,3'r,6s,9e,11r,13z,15e)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate

C22H26N2O6S3 (510.0953)

(2r,3'r,6r,9e,11r,13e,15z)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate

C22H26N2O6S3 (510.0953)

(2r,3'r,6r,9z,11r,13z,15e)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate

C22H26N2O6S3 (510.0953)

3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate

C22H26N2O6S3 (510.0953)

3,3',5,8,10'-pentahydroxy-7-methoxy-7'-methyl-3',4'-dihydro-3h-spiro[naphtho[2,3-b]furan-2,2'-pyrano[3,2-g]isochromene]-4,9,9'-trione

C25H18O12 (510.0798)